Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03837405 · ClinicalTrials.gov registry record · NA
(R33 Phase) DELISH Study: Diabetes Education to Lower Insulin, Sugars, and Hunger
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 125
- Enrollment target
NCT03837405: Completed NA study, sponsored by University of California, San Francisco.
NCT03837405 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 125 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03837405, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
Study Summary
The investigators plan an R33 phase trial in which 120 persons with type 2 diabetes (T2DM) will be randomized (using a 1:1 ratio) to education alone (Ed) on following a carbohydrate restricted diet for T2DM, or this same education content with added mindful eating/Mindfulness-Based Intervention components (Ed+MBI).
Primary Outcome
Percent of participant ketone measures \> or = 0.5 mmol/L during trial, by study arm
Interventions
- BEHAVIORAL Carbohydrate-restricted diet
- BEHAVIORAL Mindfuless
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2018-12-12 |
| Est. Completion | 2021-06-17 |
| Phase | NA |
What the finished NCT03837405 record still lists
NCT03837405 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Carbohydrate-restricted diet is the first listed.
NCT03837405 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03837405 about?
NCT03837405 is a clinical study titled "(R33 Phase) DELISH Study: Diabetes Education to Lower Insulin, Sugars, and Hunger". The investigators plan an R33 phase trial in which 120 persons with type 2 diabetes (T2DM) will be randomized (using a 1:1 ratio) to education alone (Ed) on following a carbohydrate restricted diet for T2DM, or this same education content with added mindful eating/Mindfulness-Based Intervention comp...
What is the current status of trial NCT03837405?
This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2018-12-12. Estimated completion is 2021-06-17.
What interventions are being tested in trial NCT03837405?
The interventions under investigation include: Carbohydrate-restricted diet (BEHAVIORAL), Mindfuless (BEHAVIORAL).
Who is sponsoring clinical trial NCT03837405?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03837405's enrollment target sits among peer trials
125 753rd of 2000 higher than 1,243 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI